Study of anisodine for stroke patients after clot removal
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether adding anisodine, a medicine that may protect brain cells, helps people recover better after a stroke caused by a blocked large artery in the brain. It is given after a procedure to remove the clot.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You had a stroke caused by a blockage in a large artery in the front part of the brain.
- You can start treatment within 24 hours of when you were last known to be well.
- Your stroke symptoms are moderate to severe (NIHSS score of 6 or higher).
- You were independent before the stroke (able to do daily activities without help).
- You agree to have the clot removal procedure (endovascular therapy).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a clot-busting drug called pro-urokinase can help people with a stroke in the back of the brain when given later than usual (4.5 to 9 hours after symptoms start). The goal is to see if it improves recovery and reduces disability.
This study tests whether adding a drug called human urinary kallidinogenase to standard clot-removal therapy helps people recover better after a large-vessel stroke. If you qualify, you would receive the drug or a placebo by IV along with the procedure, and doctors will monitor your recovery.
This trial tests whether Cerebrolysin (a medication given through an IV) can help improve recovery after a stroke when given after a successful clot-removal procedure that happened several hours after the stroke began. It is being tested in people who had a large-vessel stroke in the front of the brain and meets certain imaging criteria. The goal is to see if the drug can reduce disability and improve recovery.
This study looks at patients having a stroke procedure to remove a clot. It aims to predict how well people recover. If you are having this treatment, the study might help doctors understand your likely outcome.
This trial tests if a hibernation-like therapy can improve recovery after a stroke caused by a large blood clot in the brain. It is for people who are having a stroke and are scheduled for a procedure to remove the clot.
This trial tests whether a drug called urinary kallidinogenase can help people who have had a stroke caused by a blocked artery in the brain. The drug is given within 48 hours of the stroke, and the study hopes to see if it improves recovery and reduces disability.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.